Authors


Amanda Brower

Latest:

Shared appointments improve patient satisfaction, access

Although shared medical appointments are a radical departure from the traditional doctor-patient visit, they are being conducted by a handful of urologists.


Neil H. Baum, MD

Latest:

You chose to be a urologist, now count your blessings

"The next time you think about what you would do instead of becoming a doctor and especially a urologist, just stop and be thankful you chose urology," writes Neil H. Baum, MD.


Leonard S. Marks, MD

Latest:

Low-risk prostate cancer well managed with active surveillance

Drs. Scott B. Shappell and Leonard S. Marks discuss clinical use of urine PCA3 mRNA testing for prostate cancer.


Scott B. Shappell, MD, PhD

Latest:

Low-risk prostate cancer well managed with active surveillance

Drs. Scott B. Shappell and Leonard S. Marks discuss clinical use of urine PCA3 mRNA testing for prostate cancer.


Leslie M. Rickey, MD, MPH

Latest:

Transvaginal mesh: Further study of risks, benefits needed

It's not clear yet whether transvaginal mesh offers superior anatomic or symptomatic outcomes compared to traditional apical suspension repairs.


Benjamin P. Saylor

Latest:

Expert discusses unmet needs in urologic care for LGBTQ patients

"Specifically for our transgender and gender-diverse patients, there are still insurance issues and access issues in general," said Diana K. Bowen, MD.


Wayne Kuznar

Latest:

Water ablation’s safety, efficiency in BPH assessed

An image-guided technique for treating LUTS associated with BPH is reproducible and promising, researchers say.


Sivaprasad Madduri, MD

Latest:

Poem: I'm PSA and I am Furious

This was written by Sivaprasad Madduri, MD, a urologist at NorthWest Clinic, Poplar Bluff, MO.


Dominic Frimberger, MD

Latest:

Bladder augmentation: What the future holds

This article reviews current developments in cellular scaffods, the process of cell seeding, and the importance of a favorable in vitro environment for regeneration.


Ben O. Donovan, MD

Latest:

Bladder augmentation: What the future holds

This article reviews current developments in cellular scaffods, the process of cell seeding, and the importance of a favorable in vitro environment for regeneration.


Bradley P. Kropp, MD

Latest:

Bladder augmentation: What the future holds

This article reviews current developments in cellular scaffods, the process of cell seeding, and the importance of a favorable in vitro environment for regeneration.


Karen Bardossi

Latest:

Study: No significant link between diabetes Tx, bladder Ca

A new study reports no statistically significant increase in the risk of bladder cancer among patients treated with the diabetes drug pioglitazone (Actos), despite previous studies suggesting an association.


Joe Capko

Latest:

ACA changes create fresh collecting challenges for urology practices

If you’re in private practice, your profits will be directly affected by how your staff can manage and adapt to ACA-related coverage changes.


Jeffrey A. Cadeddu, MD

Latest:

Challenging case: Hematuria in man with a history of prostate Ca

A 63-year-old African-American male presents to the emergency department with sudden onset of painless gross hematuria for one day. He reports dark red urine with clots causing occasional dysuria, difficulty emptying, and light-headedness.


Casey Seideman, MD

Latest:

Laparoendoscopic single-site surgery in urologic patients: What does the future hold?

In this article, we briefly review the literature suggesting LESS is safe and holds a potential advantage over conventional laparoscopy. We then describe our techniques and outcomes for performing an extirpative (nephrectomy) and reconstructive (pyeloplasty) LESS procedure.


Aditya Bagrodia, MD

Latest:

Laparoendoscopic single-site surgery in urologic patients: What does the future hold?

In this article, we briefly review the literature suggesting LESS is safe and holds a potential advantage over conventional laparoscopy. We then describe our techniques and outcomes for performing an extirpative (nephrectomy) and reconstructive (pyeloplasty) LESS procedure.


Cheryl Guttman Krader, BS, Pharm

Latest:

Large retrospective study identifies racial disparity in surgical management for BPH

A logistic regression analysis controlling for other major comorbidities, patient age, insurance status, and type of medical therapy found that Black patients were almost 40% less likely than White patients to undergo surgery for BPH.


Louise Gagnon

Latest:

Is low-intensity surveillance feasible for patients with high-risk NMIBC?

The study compared regimens for patients with high-risk non–muscle invasive bladder cancer.


Tim Lytle

Latest:

AACU: Circumcision controversy could hike urologists' liability premiums

Controversies related to circumcision could lead to a rise in medical liability for urologists performing this procedure, writes the American Association of Clinical Urologists' Tim Lytle.


July Capko

Latest:

How to reward employees for a job well done

Here are some tips for developing an incentive plan that will keep your medical staff motivated.


Cheryl Guttman Krader, BS, Pharm

Latest:

Pre-visit BPH decision aid provides valuable insights and optimizes care

The research also showed that the decision aid was well-received by patients as both satisfaction of men who used the tool and their willingness to recommend their physician were very high.


Karen Nash

Latest:

What is your reaction to the new AMA president describing health care as being in crisis?

"The burden of preauthorization, reimbursements not keeping up with inflation, and consequently, our abilities to staff and maintain our offices and pay our employees at appropriate levels are also affecting our ability to care for patients," said urologist Ronald P. Kaufman Jr, MD.


Wayne Kuznar

Latest:

PSA disadvantages discussed with minority of men

A minority of patients are involved in shared decision-making about prostate cancer screening with PSA, but new strategies to incorporate shared decision-making into practice are being investigated.


Ja-Hong Kim, MD

Latest:

Majority of nocturia patients have nocturnal polyuria

Drs. Shlomo Raz and Ja-Hong Kim discuss recent advances in the treatment of stress incontinence.


Richard R. Kerr

Latest:

FDA approves 2 PARP inhibitors for certain men with prostate cancer

The FDA has approved 2 poly (ADP-ribose) polymerase (PARP) inhibitors for men with metastatic castration-resistant prostate cancer who have certain genetic mutations, marking the first approvals of this newer drug class in prostate cancer.


Neil Baum, MD

Latest:

UroLift vs. TURP: New gold standard for BPH?

In this video, Neil Baum, MD, compares UroLift with other BPH management strategies and also discusses his experience with the use of nitrous oxide as an effective sedative during in-office urologic procedures.


Virginia Martin, CPC, CHBC

Latest:

How to bill for a locum tenens during a transition period

There are different ways to go about billing for a locum tenens depending on your circumstances.


Adonis Hijaz, MD

Latest:

Opportunistic salpingectomy in female urologic surgery

Evidence suggests fallopian tube removal will lead to reduced ovarian cancer ­incidence.


Sam S. Chang, MD

Latest:

Cost considerations in the management of bladder cancer

"We will review the evidence and identify potential areas of improvement that can help reduce costs associated with UCB management while improving outcomes," write Daniel J. Lee, MD, and Sam S. Chang, MD.


Penny Allen

Latest:

Marijuana use prevalent among chronic prostatitis/chronic pelvic pain syndrome patients

With marijuana legalized for medical use in Canada since 2001 and now in 17 U.S. states and the District of Columbia, urology patients in pain have been turning to marijuana for relief.

© 2023 MJH Life Sciences

All rights reserved.